AzTrials
AzTrials

Doppler-Based Renal UltrasoundNCT07037485

The Predictive Value of Doppler Based Renal Ultrasound and Urinary Oxygen Tension for Prediction of Acute Kidney Injury After Open Heart Surgery

An observational study of Doppler-Based Renal Ultrasound and Urinary Oxygen Tension, run by Tanta University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to investigate the predictive value of Doppler-based renal ultrasound and urinary oxygen tension in the development of acute kidney injury after cardiac surgery. Read more about this study

Who is it for?
Ages 21 years and older
What is being tested?
Renal resistive index, Renal Artery Pulsatility Index and Urinary oxygen tension (PUO2)
How many people
50 participants
Where
1 siteEgypt
Study dates
1 Oct 2024to 1 Sep 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This prospective cohort observational study will be conducted at Tanta University Hospitals for a period of at least two years, from October 2024 to September 2026, pending approval from the institutional ethics committee.

Who may be able to join

  • Age above 21 years.
  • Both sexes.
  • Undergoing elective on-pump cardiac surgery.

Who cannot join

  • Patients with chronic kidney disease.
  • Patients with any renal pathology or anatomic kidney abnormalities.
  • Patients on renal replacement therapy.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Amany M Badr, Master contact

00201018038038

amany.badr@med.tanta.edu.eg

Egypt1 site, 1 recruiting
  • Tanta University

    Tanta, El-Gharbia, 31527

    Amany M Badr, Master, 00201018038038, amany.badr@med.tanta.edu.eg

    Ayman A Yousef, MD

    Recruiting

Other trials in Egypt

About this study

This study aims to investigate the predictive value of Doppler-based renal ultrasound and urinary oxygen tension in the development of acute kidney injury after cardiac surgery.

Read the detailed description

Cardiac surgery-associated acute kidney injury (CSA-AKI) is a complication following cardiac surgery occurring in 15-30% of patients. It is associated with increased morbidity and mortality as well as prolonged hospital stay and higher medical costs.

The renal artery pulsatility index (RAPI), which is determined using Doppler measurements, has been reported to detect patients with a high risk of AKI. Additionally, the renal resistance index (RRI), measured by Doppler ultrasound, can accurately predict the occurrence of AKI.

Urinary oxygen partial pressure in the bladder has been shown to decrease in the setting of sepsis, reduced renal blood flow, and decreased cardiac output.

Being tested
Renal resistive index, Renal Artery Pulsatility Index, Urinary oxygen tension (PUO2)
Medical subject headings
Acute Kidney Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Renal resistive indexOther

    It will be measured with ultrasound-Doppler using an abdominal curvilinear probe ultrasonography by two independent, trained sonographers (who will not be involved in patient care). After visualizing the kidney in ultrasound mode and checking for renal abnormalities, an arcuate or inter-lobar artery will be localized, and three successive Doppler measurements at different positions in the kidney (high, middle, and low) will be performed. The average value for each kidney will be taken.

    The renal resistive index will be calculated as follows:

    (systolic peak flow velocity - diastolic minimum flow velocity)/systolic peak flow velocity

  • Renal Artery Pulsatility IndexOther

    It will be measured using an abdominal curvilinear probe ultrasonography by two independent, trained sonographers (who will not be involved in patient care). After visualizing the kidney, the interlobular artery will be located using color Doppler mode, and the velocity of the interlobular arteries will be assessed in one or two kidneys.

    The Renal Artery Pulsatility Index (RAPI) will be calculated as follows:

    RAPI = [(peak systolic velocity) - (end diastolic velocity)] /average velocity

  • Urinary oxygen tension (PUO2)Other

    Urinary oxygen tension (PUO2) will be measured preoperatively (baseline), postoperatively just after intensive care unit admission, 12 hours after surgery, and then once daily for 7 days.

Study groups in NCT07037485
Study groupRoleWhat they receive
Study groupPatients undergoing elective on-pump cardiac surgery
Receives: Other: Renal resistive index; Other: Renal Artery Pulsatility Index; Other: Urinary oxygen tension (PUO2)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of cases developed acute kidney injury

    Number of cases developed acute kidney injury as defined by KIDGO guidelines (serum creatinine ≥ 0.3 mg/dL from base line within 48 hours, or ≥1.5 fold within 7 days, or urine output <0.5 mL/kg/hour for six hours) in patients undergoing open heart surgery.

    Measured: 7 days after the procedure

Secondary outcomes (5)
  1. Length of intensive care unit stay

    The length of stay in an Intensive Care Unit (ICU) is defined as the duration a patient spends in the ICU, typically measured from the time of admission to the ICU until the time of discharge.

    Measured: 7 days after the procedure

  2. Length of hospital stay

    Length of hospital stay will be measured from admission till discharge from hospital.

    Measured: 7 days after the procedure

  3. Need for renal replacement therapy

    Need for renal replacement therapy will be recorded.

    Measured: 7 days after the procedure

  4. Number of patients developed chronic kidney disease

    Number of patients developed chronic kidney disease will be recorded.

    Measured: 7 days after the procedure

  5. Mortality rate

    Mortality rate will be recorded.

    Measured: 7 days after the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2025
  2. Study start1 Oct 2024
  3. Primary completion1 Sep 2026 (estimated)
  4. Study completion1 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07037485
Sponsor's protocol ID
36265MD279/9/24
Status last verified
Jun 2025
First submitted
17 Jun 2025
Last updated
25 Jun 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Questions about this trial

What is this clinical trial studying?

An observational study of Doppler-Based Renal Ultrasound and Urinary Oxygen Tension, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Amany M Badr, Master (00201018038038, amany.badr@med.tanta.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of cases developed acute kidney injury (time frame: 7 days after the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in